Tag: study

Daix (France), New York City (New York, United States), July 9, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced a leadership transition with the appointment of Jason Campagna, MD, PhD, as President of Research and Development (“R&D”) and Chief Medical Officer (“CMO”) and Martine Zimmermann, PharmD, as Executive Vice President (“EVP”) of Regulatory Affairs and Quality Assurance.

Data from Orbit and Cosmic studies expected around the end of the year

The global logistics market size is expected to be worth approximately USD 23.14 trillion by 2034, increasing from USD 11.23 trillion in 2025, fueled by booming e-commerce, tech adoption, and infrastructure initiatives.

Veteran clinical leader with successful track record and experience to help guide the Company’s clinical strategy in Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Surging demand for immersive storytelling, real-time virtual production, and reduced post-production costs are driving the ICVFX market, with over 60% of major studios integrating ICVFX in their production pipelines. This shift enhances creative flexibility, accelerates content delivery, and sets new standards for cinematic visual excellence.

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registrational study and accelerating time to potential approval